Applications including "USP"

LB902 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18
LB901 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18
LB900 - Analysis of Fesoterodine Fumarate -

LC InertSearch InertSustain C8
LB899 - Analysis of Fesoterodine Fumarate -

LC InertSearch InertSustainSwift C18
GA352 - Analysis of Dipropylene Glycol -

GC InertSearch InertCap WAX-HT
GA351 - Analysis of Dextran 40 -

GC InertSearch InertCap 1
LB896 - Analysis of Triptorelin Pamoate -

LC InertSearch InertSustain C18
LB895 - Analysis of Venlafaxine hydrochloride -

LC InertSearch InertSustainSwift C8
LB894 - Analysis of Ursodiol -

LC InertSearch Inertsil WP300
LB891 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18 HP
LB890 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18 HP
LB889 - Analysis of Propyl gallate -

LC InertSearch Inertsil WP300
LB888 - Analysis of Propyl gallate -

LC InertSearch Inertsil WP300
LB887 - Analysis of Propyl gallate -

LC InertSearch Inertsil ODS-4
LB885 - Analysis of Voriconazole -

LC InertSearch InertSustain C18
LB884 - Analysis of Voriconazole -

LC InertSearch InertSustain C18
LB883 - Analysis of Paclitaxel -

LC InertSearch InertSustain PFP
LB876 - Analysis of Cefoxitin -

LC InertSearch InertSustain C18
LB875 - Analysis of Levofloxacin -

LC InertSearch Inertsil ODS-3
LB859 - Analysis of Amoxicillin and Clavulanate potassium -

LC InertSearch Inertsil ODS-3
LB829 - Analysis of Sulfamethoxazole and Trimethoprim -

LC InertSearch Inertsil WP300 C18
LB828 - Analysis of Chloroprocaine Hydrochloride -

LC InertSearch InertSustain C18
LB751 - Analysis ofSulfamethoxazole and Trimethoprim -

LC InertSearch Inertsil WP300 C18
LB749 - Analysis of Ibuprofen（Under the Condeition of USP43-NF38) -

LC InertSearch Inertsil WP300 C18
LB745 - Analysis of of Metformin Hydrochloride Tablets（Under the Condeition of USP43-NF38, Glyburide and Metformin Hydrochloride Tablets) -

LC InertSearch InertSustain C18
LB740 - Analysis of Acetaminophen -

LC InertSearch Inertsil ODS-3
LB739 - Analysis of Acetaminophen -

LC InertSearch Inertsil ODS-3
LB696 - Analysis of Trifluoroacetic acid -

LC InertSearch InertSustain AQ-C18
LB695 - Analysis of acetic acid （USP） -

LC InertSearch InertSustainSwift C18
LB687 - Analysis of Ampicillin Hydrate -

LC InertSearch Inertsil ODS-4
LB681 - Analysis of Moxifloxacin -

LC InertSearch InertSustain Phenylhexyl
LB679 - Analysis of Cetylpyridinium chloride -

LC InertSearch InertSustain AX-C18
LB639 - Analysis of Levetiracetam (Under the Condition of USP42-NF37 1S, Levetiracetam Oral Solution) -

LC InertSearch InertSustainSwift C18
LB638 - Analysis of Levetiracetam (Under the Condition of USP42-NF37 1S, Levetiracetam Oral Solution) -

LC InertSearch InertSustain C18
LB637 - Analysis of Levetiracetam (Under the Condition of USP42-NF37 1S, Levetiracetam Extended-Release Tablets) -

LC InertSearch InertSustain C8
LB636 - Analysis of Levetiracetam (Under the Condition of USP42-NF37 1S, Levetiracetam Tablets) -

LC InertSearch InertSustainSwift C18
LB635 - Analysis of Levetiracetam (Under the Condition of draft for USP) -

LC InertSearch InertSustain AQ-C18 HP
LB634 - Analysis of Rivaroxaban (Under the Condition of draft for USP, Rivaroxaban Tablets) -

LC InertSearch InertSustainSwift C18
LB633 - Analysis of Rivaroxaban (Under the Condition of draft for USP) -

LC InertSearch InertSustainSwift C18
LB625 - Analysis of Prasugrel hydrochloride (Under the Condition of USP42-NF37) -

LC InertSearch InertSustainSwift C18
LB624 - Analysis of Etoposide phosphate (Under the Condition of draft for USP) -

LC InertSearch InertSustain Phenyl
LB623 - Analysis of Etoposide phosphate (Under the Condition of draft for USP) -

LC InertSearch InertSustain Phenyl
LB622 - Analysis of Venlafaxine hydrochloride (Under the Condition of USP41-NF36, Venlafaxine Hydrochloride Extended-Release Capsules) -

LC InertSearch InertSustain C18
LB621 - Analysis of Venlafaxine hydrochloride (Under the Condition of USP41-NF36, Venlafaxine Hydrochloride Extended-Release Capsules) -

LC InertSearch InertSustain C18
LB620 - Analysis of Venlafaxine hydrochloride (Under the Condition of USP41-NF36, Venlafaxine Tablets) -

LC InertSearch InertSustain C18
LB619 - Analysis of Venlafaxine hydrochloride (Under the Condition of USP41-NF36, Venlafaxine Hydrochloride) -

LC InertSearch InertSustain C8
LB618 - Analysis of Pregabalin (Under the Condition of USP41-NF36, Pregabalin) -

LC InertSearch Inertsil ODS-3
LB616 - Analysis of Levocetirizine (Under the Condition of USP41-NF36, Levocetirizine Dihydrochloride) -

LC InertSearch Inertsil SIL-100A
LB615 - Analysis of Cromolyn (Under the Condition of USP41-NF36, Cromolyn Sodium) -

LC InertSearch InertSustain C18
LT159 - Assay Test for Esomeprazole Magnesium Delayed -Release Capsules under USP Method -

LC Technical Note InertSustain C18
LT147 - D-Mannitol Analysis Under USP Method -

LC Technical Note InertSphere Sugar-2 HAMILTON HC-75（Ca2+）
LT131 - HPLC Columns Compliant with Pharmacopoeia (USP, EP and JP） -

LC Technical Note
LT099 - Analysis of Valsartan -

LC Technical Note InertSustain C18
LT098 - Analysis of Amlodipine -

LC Technical Note Inertsil ODS-4 HP
LT097 - Analysis of Pioglitazone Hydrocloride -

LC Technical Note Inertsil ODS-4 HP
LT096 - Analysis of Atorvastatin Calcium -

LC Technical Note Inertsil C8-4 Inertsil C8-4 HP
LB556 - Analysis of Mirtazapine -

LC InertSearch InertSustain C18
LB555 - Analysis of Mirtazapine (Under the Condition of draft for USP, Mirtazapine Compounded Oral Suspension, Veterinary) -

LC InertSearch Inertsil ODS-3
LB554 - Analysis of Mirtazapine (Under the Condition of USP41-NF36, Mirtazapine Orally Disintegrating Tablets) -

LC InertSearch InertSustainSwift C18
LB553 - Analysis of Mirtazapine (Under the Condition of USP41-NF36, Mirtazapine Tablets) -

LC InertSearch InertSustain C18
LB552 - Analysis of Mirtazapine (Under the Condition of USP41-NF36, Mirtazapine) -

LC InertSearch InertSustain C18
LB551 - Analysis of Ezetimibe (Under the Condition of USP41-NF36, Ezetimibe Tablets) -

LC InertSearch InertSustainSwift C18
LB550 - Analysis of Ezetimibe (Under the Condition of USP41-NF36, Ezetimibe Tablets) -

LC InertSearch InertSustainSwift C18
LB549 - Analysis of Ezetimibe (Under the Condition of USP41-NF36, Ezetimibe) -

LC InertSearch InertSustain PFP
LB548 - Analysis of Sitagliptin (Under the Condition of draft for USP, Sitagliptin and Metformin Hydrochloride Tablets) -

LC InertSearch InertSustain C18
LB547 - Analysis of Sitagliptin (Under the Condition of draft for USP, Sitagliptin and Metformin Hydrochloride Tablets) -

LC InertSearch InertSustain C18
LB546 - Analysis of Cinacalcet Hydrochloride (Under the Condition of draft for USP) -

LC InertSearch InertSustainSwift C18
LB545 - Analysis of Cinacalcet Hydrochloride (Under the Condition of draft for USP) -

LC InertSearch InertSustainSwift C18
LB536 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of USP41-NF36, Telmisartan and Hydrochlorothiazide Tablets) -

LC InertSearch InertSustain C18
LB535 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of USP41-NF36, Telmisartan and Hydrochlorothiazide Tablets) -

LC InertSearch InertSustainSwift C8
LB534 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of USP41-NF36, Telmisartan and Hydrochlorothiazide Tablets) -

LC InertSearch InertSustain C8
LB533 - Analysis of Dexamathasone Sodium Phosphate (Under the Condition of USP41-NF36, Dexamathasone Sodium Phosphate) -

LC InertSearch Inertsil ODS-3
LB512 - Analysis of Pioglitazone hydrochloride （Under the Condition of the draft for USP） -

LC InertSearch InertSustain C18
LB476 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LC InertSearch Inertsil Ph
LB475 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LC InertSearch Inertsil Ph-3
LB474 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LC InertSearch InertSustain Phenylhexyl
LB473 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LC InertSearch InertSustain Phenyl
LB463 - Analysis of Ibuprofen (Under the Condition of USP 39-NF34, Ibuprofen Oral Suspension) -

LC InertSearch InertSustain C8
LB462 - Analysis of Cephalexin (Under the Condition of USP 39-NF34) -

LC InertSearch InertSustain C18
LB461 - Analysis of Phenylephrine Hydrochloride (Under the Condition of USP 39-NF34, Phenylephrine Hydrochloride Injection) -

LC InertSearch InertSustain C18
LB460 - Analysis of Estradiol (Under the Condition of USP 39-NF34) -

LC InertSearch Inertsil ODS-3
LB459 - Analysis of Acetaminophen (Under the Condition of USP 39-NF34, Acetaminophen Capsules) -

LC InertSearch Inertsil ODS-3
LB458 - Analysis of Glyburide (Under the Condition of USP 39-NF34) -

LC InertSearch Inertsil C8
LB414 - Analysis of Esomeprazole magnesium (Under the Condition of USP 38-NF33, Esomeprazole magnesium Extended-release Tablets) -

LC InertSearch InertSustain C18
LB287 - Analysis of Sugar Spheres (Under the Condition of USP 37-NF32) -

LC InertSearch Inertsil NH2
LB200 - Analysis of Losartan potassium and Hydrochlorothiazide (Under the Condition of USP 35-NF30, Losartan potassium and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil C8-3
LA943 - Analysis of Azithromycin -

LC InertSearch InertSustain C18
LA939 - Analysis of Losartan Potassium (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LA938 - Analysis of Losartan Potassium (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LA937 - Analysis of Losartan Potassium (Inertsil ODS-3) -

LC InertSearch Inertsil ODS-3
LA936 - Analysis of Losartan Potassium (Inertsil ODS-3) -

LC InertSearch Inertsil ODS-3
LA922 - Analysis of Atorvastatin tablet -

LC InertSearch Inertsil C8-4
LA921 - Analysis of Atorvastatin -

LC InertSearch Inertsil C8-4
LA904 - Analysis of Bilberry extract (InertSustain C18) -

LC InertSearch InertSustain C18
LA898 - Analysis of Donepezil Hydrochloride-Impurities (Inertsil ODS-3) -

LC InertSearch Inertsil ODS-3
LA897 - Analysis of Donepezil Hydrochloride-Impurities (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
GT107 - Simple Concentration Analysis of Lavender Flavor Components - Using MonoTrap RCC18 (solvent-extraction) -

GC Technical Note InertCap Pure-WAX
GT101 - Analysis of memantine hydrochloride in accordance with the USP -

GC Technical Note
GA291 - Memantine Hydrochloride(Under the Condition of United States Pharmacopeia 39, Organic Impurities) -

GC InertSearch InertCap 5
GA290 - Memantine Hydrochloride(Under the Condition of United States Pharmacopeia 39, Assay) -

GC InertSearch InertCap 5

Applications including "USP"

LB902 - Analysis of Saxagliptin -

LB901 - Analysis of Saxagliptin -

LB900 - Analysis of Fesoterodine Fumarate -

LB899 - Analysis of Fesoterodine Fumarate -

GA352 - Analysis of Dipropylene Glycol -

GA351 - Analysis of Dextran 40 -

LB896 - Analysis of Triptorelin Pamoate -

LB895 - Analysis of Venlafaxine hydrochloride -

LB894 - Analysis of Ursodiol -

LB891 - Analysis of Saxagliptin -

LB890 - Analysis of Saxagliptin -

LB889 - Analysis of Propyl gallate -

LB888 - Analysis of Propyl gallate -

LB887 - Analysis of Propyl gallate -

LB885 - Analysis of Voriconazole -

LB884 - Analysis of Voriconazole -

LB883 - Analysis of Paclitaxel -

LB876 - Analysis of Cefoxitin -

LB875 - Analysis of Levofloxacin -

LB859 - Analysis of Amoxicillin and Clavulanate potassium -

LB829 - Analysis of Sulfamethoxazole and Trimethoprim -

LB828 - Analysis of Chloroprocaine Hydrochloride -

LB751 - Analysis ofSulfamethoxazole and Trimethoprim -

LB749 - Analysis of Ibuprofen（Under the Condeition of USP43-NF38) -

LB745 - Analysis of of Metformin Hydrochloride Tablets（Under the Condeition of USP43-NF38, Glyburide and Metformin Hydrochloride Tablets) -

LB740 - Analysis of Acetaminophen -

LB739 - Analysis of Acetaminophen -

LB696 - Analysis of Trifluoroacetic acid -

LB695 - Analysis of acetic acid （USP） -

LB687 - Analysis of Ampicillin Hydrate -

LB681 - Analysis of Moxifloxacin -

LB679 - Analysis of Cetylpyridinium chloride -

LB639 - Analysis of Levetiracetam (Under the Condition of USP42-NF37 1S, Levetiracetam Oral Solution) -

LB638 - Analysis of Levetiracetam (Under the Condition of USP42-NF37 1S, Levetiracetam Oral Solution) -

LB637 - Analysis of Levetiracetam (Under the Condition of USP42-NF37 1S, Levetiracetam Extended-Release Tablets) -

LB636 - Analysis of Levetiracetam (Under the Condition of USP42-NF37 1S, Levetiracetam Tablets) -

LB635 - Analysis of Levetiracetam (Under the Condition of draft for USP) -

LB634 - Analysis of Rivaroxaban (Under the Condition of draft for USP, Rivaroxaban Tablets) -

LB633 - Analysis of Rivaroxaban (Under the Condition of draft for USP) -

LB625 - Analysis of Prasugrel hydrochloride (Under the Condition of USP42-NF37) -

LB624 - Analysis of Etoposide phosphate (Under the Condition of draft for USP) -

LB623 - Analysis of Etoposide phosphate (Under the Condition of draft for USP) -

LB622 - Analysis of Venlafaxine hydrochloride (Under the Condition of USP41-NF36, Venlafaxine Hydrochloride Extended-Release Capsules) -

LB621 - Analysis of Venlafaxine hydrochloride (Under the Condition of USP41-NF36, Venlafaxine Hydrochloride Extended-Release Capsules) -

LB620 - Analysis of Venlafaxine hydrochloride (Under the Condition of USP41-NF36, Venlafaxine Tablets) -

LB619 - Analysis of Venlafaxine hydrochloride (Under the Condition of USP41-NF36, Venlafaxine Hydrochloride) -

LB618 - Analysis of Pregabalin (Under the Condition of USP41-NF36, Pregabalin) -

LB616 - Analysis of Levocetirizine (Under the Condition of USP41-NF36, Levocetirizine Dihydrochloride) -

LB615 - Analysis of Cromolyn (Under the Condition of USP41-NF36, Cromolyn Sodium) -

LT159 - Assay Test for Esomeprazole Magnesium Delayed -Release Capsules under USP Method -

LT147 - D-Mannitol Analysis Under USP Method -

LT131 - HPLC Columns Compliant with Pharmacopoeia (USP, EP and JP） -

LT099 - Analysis of Valsartan -

LT098 - Analysis of Amlodipine -

LT097 - Analysis of Pioglitazone Hydrocloride -

LT096 - Analysis of Atorvastatin Calcium -

LB556 - Analysis of Mirtazapine -

LB555 - Analysis of Mirtazapine (Under the Condition of draft for USP, Mirtazapine Compounded Oral Suspension, Veterinary) -

LB554 - Analysis of Mirtazapine (Under the Condition of USP41-NF36, Mirtazapine Orally Disintegrating Tablets) -

LB553 - Analysis of Mirtazapine (Under the Condition of USP41-NF36, Mirtazapine Tablets) -

LB552 - Analysis of Mirtazapine (Under the Condition of USP41-NF36, Mirtazapine) -

LB551 - Analysis of Ezetimibe (Under the Condition of USP41-NF36, Ezetimibe Tablets) -

LB550 - Analysis of Ezetimibe (Under the Condition of USP41-NF36, Ezetimibe Tablets) -

LB549 - Analysis of Ezetimibe (Under the Condition of USP41-NF36, Ezetimibe) -

LB548 - Analysis of Sitagliptin (Under the Condition of draft for USP, Sitagliptin and Metformin Hydrochloride Tablets) -

LB547 - Analysis of Sitagliptin (Under the Condition of draft for USP, Sitagliptin and Metformin Hydrochloride Tablets) -

LB546 - Analysis of Cinacalcet Hydrochloride (Under the Condition of draft for USP) -

LB545 - Analysis of Cinacalcet Hydrochloride (Under the Condition of draft for USP) -

LB536 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of USP41-NF36, Telmisartan and Hydrochlorothiazide Tablets) -

LB535 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of USP41-NF36, Telmisartan and Hydrochlorothiazide Tablets) -

LB534 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of USP41-NF36, Telmisartan and Hydrochlorothiazide Tablets) -

LB533 - Analysis of Dexamathasone Sodium Phosphate (Under the Condition of USP41-NF36, Dexamathasone Sodium Phosphate) -

LB512 - Analysis of Pioglitazone hydrochloride （Under the Condition of the draft for USP） -

LB476 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LB475 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LB474 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LB473 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LB463 - Analysis of Ibuprofen (Under the Condition of USP 39-NF34, Ibuprofen Oral Suspension) -

LB462 - Analysis of Cephalexin (Under the Condition of USP 39-NF34) -